Talymed® advanced sterile wound matrix is composed of shortened fibers of poly-N-acetyl glucosamine (pGlcNac), isolated from microalgae.
• Accelerates wound closure by reepithelialization and increased keratinocyte migration
Talymed® is indicated for the management of wounds including: diabetic ulcers, venous ulcers, pressure wounds, ulcers caused by mixed vascular and other bleeding surface wounds, abrasions, lacerations, traumatic wounds healing by secondary intention, chronic vascular ulcers, and dehisced surgical wounds.
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner.
Talymed® is packaged in a blister pack and can be stored at room temperature for up to 3 years.
Open blister pack onto sterile field, position Talymed® onto the wound bed to ensure 100% coverage and affix to skin using adhesive skin closure tape. Talymed® conforms to wound bed. Apply non-adherent primary dressing and secondary dressing based on wound characterization and amount of exudate.
Talymed® advanced wound matrix is composed of shortened fibers of poly-N-acetyl glucosamine (pGlcNAc) isolated from microalgae.
No posters match your selected filters. Remove some filtres, or reset them and start again.